National Institutes of Health approves use of stem cell lines

02/19/2014 | Australian Life Scientist

The National Institutes of Health's Human Embryonic Stem Cell Registry has approved the use of 52 human embryonic stem cell lines of Genea Biocells in the U.S. Of the 52 hESCs approved, 43 disease-specific hESC lines represent 24 genetic diseases. These included cell lines expressing genes coding for genetic cancers and metabolic, vascular and eye conditions, while the remaining nine cell lines are from different genetic backgrounds. The stem cell lines will be used to support research and development of new treatments.

View Full Article in:

Australian Life Scientist

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ